- Resources
Budesonide Ec
This is a study to compare the effects of budesonide-MMX to Asacol versus a placebo in patients with ulcerative colitis. This national study is currently recruiting adults ages 18 years to 75 years old who have this condition and meet other study requirements.
Read moreMore information on "Budesonide Ec"
From Our Experts
Advair and Symbicort: “Benefits Outweigh Risk” says an FDA...
Last week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory... Read more »
Update on Pulmicort : From Turbuhaler to Flexhaler
According to the recently revised National Institute of Health asthma guidelines, inhaled corticosteroids are the preferred class of... Read more »
New Guidelines for Treatment of Asthma in Pregnant Women
Pregnancy can be one of most joyful periods in life, provided the woman is feeling well. But, if you're not feeling well due to abdominal... Read more »
Asthma Control During Pregnancy is Essential
A new review published in the May-June issue of the Journal of the American Board of Family Medicine emphasizes the importance of asthma... Read more »
New Asthma Steroid Now Available in the US
Asthma treatment, as with many chronic diseases, is often a matter of trial and error. Experts know that most people with asthma respond... Read more »
From Our Sources
Steroid nasal wash may ease sinusitis
Chronic sinusitis--a frustrating and painful disorder that affects up to 14 percent of Americans--may be eased with a steroid nasal wash, a small... Read more »
Symbicort works faster than Advair on COPD
Data from a study comparing Symbicort (budesonide, formoterol), Advair (fluticasone propionate, salmeterol), and salbutamol has found that... Read more »
Clinical trial: Imuran dosing study for Crohn's patients
This is a study to determine the best dose of Imuran for patients with Crohn's disease who are currently taking the steroids prednisone or... Read more »
Asthma drug Symbicort approved by FDA
The Food and Drug Administration has approved a new combination treatment, Symbicort, for the treatment of asthma in people ages 12 and older.... Read more »
Using Symbicort as a "rescue" drug may cut risk of severe atta...
A new study has found that using Symbicort as both a preventative asthma medicine and as a "rescue" drug cuts asthma patients' risk of having severe... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
